GlaxoSmithKline PLC’s malaria vaccine, RTS,S/AS01 was launched on 23 April in Malawi as part of a “landmark” pilot that will generate evidence to inform World Health Organization policy recommendations on the wider use of the vaccine. Launches in Ghana and Kenya are set to follow over the next few weeks.
The Malaria Vaccine Implementation Program is being coordinated by the World Health Organization in collaboration with health ministries from the...







